The reason for these findings may lie in different patient cohort compositions as well as in study design and endpoints: our study explores the predictive ability of [TIMP-2]∙[IGFBP7] for AKI at any stage within 7 days in a multidisciplinary ICU population. The gene discussed is IGFBP7; the disease is acute kidney injury.